Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
A new era of immuno-oncology has arrived
Fierce Biotech
Fri, 12/26/14 - 10:17 am
immuno-oncology
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Amgen
AstraZeneca
Early Opdivo OK gives BMS more time to erase Keytruda's lead
Medical Marketing and Media
Wed, 12/24/14 - 09:29 am
Opdivo
Bristol-Myers Squibb
Keytruda
melanoma
Merck drug shrank tumors in some breast cancer patients in trial
Marketwatch
Wed, 12/10/14 - 09:44 am
Merck
Keytruda
triple-negative breast cancer
Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/7/14 - 10:19 am
Merck
Keytruda
Hodgkin's lymphoma
Merck grabs another 'breakthrough' in PD-1 lung cancer race with Bristol-Myers
Fierce Biotech
Mon, 10/27/14 - 09:10 am
Merck
Bristol-Myers Squibb
anti-PD-1 immunotherapy
lung cancer
Keytruda
Roche, Merck extend immunotherapy fight to breast cancer
Yahoo/Reuters
Fri, 10/17/14 - 10:08 am
Roche
Merck
breast cancer
MPDL3280A
Keytruda
Merck immunotherapy drug shows promise in bladder cancer
Yahoo/Reuters
Mon, 09/29/14 - 07:52 am
Merck
bladder cancer
immunotherapy
Keytruda
MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at
Yahoo/BusinessWire
Sun, 09/28/14 - 10:10 am
Merck
Pembrolizumab
gastric cancer
Keytruda
BMS striving to push Opdivo past Keytruda
Medical Marketing and Media
Wed, 09/17/14 - 09:52 am
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
anti-PD-1 immunotherapy
Merck's Mantra On Focus Precludes An Inversion Strategy
Forbes
Mon, 09/15/14 - 08:47 am
Merck
tax inversions
Keytruda
melanoma
Merck's Keytruda is shipping
Medical Marketing and Media
Fri, 09/12/14 - 08:48 am
Merck
Keytruda
anti-PD-1 immunotherapy
Keytruda Cancer Drug Approval Is A Triumph For Merck: R&D Chief Roger Perlmutter On What's Next
Forbes
Mon, 09/8/14 - 12:28 pm
Merck
Keytruda
R&D
Roger Perlmutter
Merck's Anti-PD-1 Drug Keytruda First to be Launched in US
Yahoo/Zacks
Sat, 09/6/14 - 09:11 am
Keytruda
Merck
melanoma
Bristol-Myers Sues Merck Over Cancer Immunotherapy Patent
Bloomberg
Fri, 09/5/14 - 04:02 pm
Bristol-Myers Squibb
Merck
Keytruda
Cancer Drug Approval Is A Triumph For Merck. What's Next?
Forbes
Fri, 09/5/14 - 10:04 am
Merck
melanoma
Keytruda
Bristol-Myers Squibb
Opdivo
FDA OKs Merck melanoma drug, 1st in new class of cancer drugs with big advantages over chemo
Yahoo/AP
Thu, 09/4/14 - 06:11 pm
Merck
FDA
melanoma
Keytruda
Pages
« first
‹ previous
…
21
22
23
24
25
26
27
28
29